Global Leukemia Therapeutic Market Research Report 2024

Report ID: 1924131 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Leukemia Therapeutic Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Induction Therapy
        1.2.3 Consolidation Therapy
        1.2.4 Maintenance Therapy
    1.3 Market by Application
        1.3.1 Global Leukemia Therapeutic Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Cancer Research Centers
        1.3.3 Diagnostic Laboratories
        1.3.4 Hospitals andClinics
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Leukemia Therapeutic Market Perspective (2018-2029)
    2.2 Leukemia Therapeutic Growth Trends by Region
        2.2.1 Global Leukemia Therapeutic Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Leukemia Therapeutic Historic Market Size by Region (2018-2023)
        2.2.3 Leukemia Therapeutic Forecasted Market Size by Region (2024-2029)
    2.3 Leukemia Therapeutic Market Dynamics
        2.3.1 Leukemia Therapeutic Industry Trends
        2.3.2 Leukemia Therapeutic Market Drivers
        2.3.3 Leukemia Therapeutic Market Challenges
        2.3.4 Leukemia Therapeutic Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Leukemia Therapeutic Players by Revenue
        3.1.1 Global Top Leukemia Therapeutic Players by Revenue (2018-2023)
        3.1.2 Global Leukemia Therapeutic Revenue Market Share by Players (2018-2023)
    3.2 Global Leukemia Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Leukemia Therapeutic Revenue
    3.4 Global Leukemia Therapeutic Market Concentration Ratio
        3.4.1 Global Leukemia Therapeutic Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Leukemia Therapeutic Revenue in 2022
    3.5 Leukemia Therapeutic Key Players Head office and Area Served
    3.6 Key Players Leukemia Therapeutic Product Solution and Service
    3.7 Date of Enter into Leukemia Therapeutic Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Leukemia Therapeutic Breakdown Data by Type
    4.1 Global Leukemia Therapeutic Historic Market Size by Type (2018-2023)
    4.2 Global Leukemia Therapeutic Forecasted Market Size by Type (2024-2029)
5 Leukemia Therapeutic Breakdown Data by Application
    5.1 Global Leukemia Therapeutic Historic Market Size by Application (2018-2023)
    5.2 Global Leukemia Therapeutic Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Leukemia Therapeutic Market Size (2018-2029)
    6.2 North America Leukemia Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Leukemia Therapeutic Market Size by Country (2018-2023)
    6.4 North America Leukemia Therapeutic Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Leukemia Therapeutic Market Size (2018-2029)
    7.2 Europe Leukemia Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Leukemia Therapeutic Market Size by Country (2018-2023)
    7.4 Europe Leukemia Therapeutic Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Leukemia Therapeutic Market Size (2018-2029)
    8.2 Asia-Pacific Leukemia Therapeutic Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Leukemia Therapeutic Market Size by Region (2018-2023)
    8.4 Asia-Pacific Leukemia Therapeutic Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Leukemia Therapeutic Market Size (2018-2029)
    9.2 Latin America Leukemia Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Leukemia Therapeutic Market Size by Country (2018-2023)
    9.4 Latin America Leukemia Therapeutic Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Leukemia Therapeutic Market Size (2018-2029)
    10.2 Middle East & Africa Leukemia Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Leukemia Therapeutic Market Size by Country (2018-2023)
    10.4 Middle East & Africa Leukemia Therapeutic Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Genzyme
        11.1.1 Genzyme Company Detail
        11.1.2 Genzyme Business Overview
        11.1.3 Genzyme Leukemia Therapeutic Introduction
        11.1.4 Genzyme Revenue in Leukemia Therapeutic Business (2018-2023)
        11.1.5 Genzyme Recent Development
    11.2 Novartis International
        11.2.1 Novartis International Company Detail
        11.2.2 Novartis International Business Overview
        11.2.3 Novartis International Leukemia Therapeutic Introduction
        11.2.4 Novartis International Revenue in Leukemia Therapeutic Business (2018-2023)
        11.2.5 Novartis International Recent Development
    11.3 Pfizer
        11.3.1 Pfizer Company Detail
        11.3.2 Pfizer Business Overview
        11.3.3 Pfizer Leukemia Therapeutic Introduction
        11.3.4 Pfizer Revenue in Leukemia Therapeutic Business (2018-2023)
        11.3.5 Pfizer Recent Development
    11.4 Roche Holding
        11.4.1 Roche Holding Company Detail
        11.4.2 Roche Holding Business Overview
        11.4.3 Roche Holding Leukemia Therapeutic Introduction
        11.4.4 Roche Holding Revenue in Leukemia Therapeutic Business (2018-2023)
        11.4.5 Roche Holding Recent Development
    11.5 Celgene Corporation
        11.5.1 Celgene Corporation Company Detail
        11.5.2 Celgene Corporation Business Overview
        11.5.3 Celgene Corporation Leukemia Therapeutic Introduction
        11.5.4 Celgene Corporation Revenue in Leukemia Therapeutic Business (2018-2023)
        11.5.5 Celgene Corporation Recent Development
    11.6 Ariad Pharmaceuticals
        11.6.1 Ariad Pharmaceuticals Company Detail
        11.6.2 Ariad Pharmaceuticals Business Overview
        11.6.3 Ariad Pharmaceuticals Leukemia Therapeutic Introduction
        11.6.4 Ariad Pharmaceuticals Revenue in Leukemia Therapeutic Business (2018-2023)
        11.6.5 Ariad Pharmaceuticals Recent Development
    11.7 Clavis Pharma
        11.7.1 Clavis Pharma Company Detail
        11.7.2 Clavis Pharma Business Overview
        11.7.3 Clavis Pharma Leukemia Therapeutic Introduction
        11.7.4 Clavis Pharma Revenue in Leukemia Therapeutic Business (2018-2023)
        11.7.5 Clavis Pharma Recent Development
    11.8 Sunesis Pharmaceuticals
        11.8.1 Sunesis Pharmaceuticals Company Detail
        11.8.2 Sunesis Pharmaceuticals Business Overview
        11.8.3 Sunesis Pharmaceuticals Leukemia Therapeutic Introduction
        11.8.4 Sunesis Pharmaceuticals Revenue in Leukemia Therapeutic Business (2018-2023)
        11.8.5 Sunesis Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Leukemia Therapeutic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Induction Therapy
    Table 3. Key Players of Consolidation Therapy
    Table 4. Key Players of Maintenance Therapy
    Table 5. Global Leukemia Therapeutic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Leukemia Therapeutic Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 7. Global Leukemia Therapeutic Market Size by Region (2018-2023) & (US$ Million)
    Table 8. Global Leukemia Therapeutic Market Share by Region (2018-2023)
    Table 9. Global Leukemia Therapeutic Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 10. Global Leukemia Therapeutic Market Share by Region (2024-2029)
    Table 11. Leukemia Therapeutic Market Trends
    Table 12. Leukemia Therapeutic Market Drivers
    Table 13. Leukemia Therapeutic Market Challenges
    Table 14. Leukemia Therapeutic Market Restraints
    Table 15. Global Leukemia Therapeutic Revenue by Players (2018-2023) & (US$ Million)
    Table 16. Global Leukemia Therapeutic Market Share by Players (2018-2023)
    Table 17. Global Top Leukemia Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukemia Therapeutic as of 2022)
    Table 18. Ranking of Global Top Leukemia Therapeutic Companies by Revenue (US$ Million) in 2022
    Table 19. Global 5 Largest Players Market Share by Leukemia Therapeutic Revenue (CR5 and HHI) & (2018-2023)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Leukemia Therapeutic Product Solution and Service
    Table 22. Date of Enter into Leukemia Therapeutic Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Leukemia Therapeutic Market Size by Type (2018-2023) & (US$ Million)
    Table 25. Global Leukemia Therapeutic Revenue Market Share by Type (2018-2023)
    Table 26. Global Leukemia Therapeutic Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Global Leukemia Therapeutic Revenue Market Share by Type (2024-2029)
    Table 28. Global Leukemia Therapeutic Market Size by Application (2018-2023) & (US$ Million)
    Table 29. Global Leukemia Therapeutic Revenue Market Share by Application (2018-2023)
    Table 30. Global Leukemia Therapeutic Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 31. Global Leukemia Therapeutic Revenue Market Share by Application (2024-2029)
    Table 32. North America Leukemia Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. North America Leukemia Therapeutic Market Size by Country (2018-2023) & (US$ Million)
    Table 34. North America Leukemia Therapeutic Market Size by Country (2024-2029) & (US$ Million)
    Table 35. Europe Leukemia Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. Europe Leukemia Therapeutic Market Size by Country (2018-2023) & (US$ Million)
    Table 37. Europe Leukemia Therapeutic Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Asia-Pacific Leukemia Therapeutic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 39. Asia-Pacific Leukemia Therapeutic Market Size by Region (2018-2023) & (US$ Million)
    Table 40. Asia-Pacific Leukemia Therapeutic Market Size by Region (2024-2029) & (US$ Million)
    Table 41. Latin America Leukemia Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 42. Latin America Leukemia Therapeutic Market Size by Country (2018-2023) & (US$ Million)
    Table 43. Latin America Leukemia Therapeutic Market Size by Country (2024-2029) & (US$ Million)
    Table 44. Middle East & Africa Leukemia Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Middle East & Africa Leukemia Therapeutic Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Middle East & Africa Leukemia Therapeutic Market Size by Country (2024-2029) & (US$ Million)
    Table 47. Genzyme Company Detail
    Table 48. Genzyme Business Overview
    Table 49. Genzyme Leukemia Therapeutic Product
    Table 50. Genzyme Revenue in Leukemia Therapeutic Business (2018-2023) & (US$ Million)
    Table 51. Genzyme Recent Development
    Table 52. Novartis International Company Detail
    Table 53. Novartis International Business Overview
    Table 54. Novartis International Leukemia Therapeutic Product
    Table 55. Novartis International Revenue in Leukemia Therapeutic Business (2018-2023) & (US$ Million)
    Table 56. Novartis International Recent Development
    Table 57. Pfizer Company Detail
    Table 58. Pfizer Business Overview
    Table 59. Pfizer Leukemia Therapeutic Product
    Table 60. Pfizer Revenue in Leukemia Therapeutic Business (2018-2023) & (US$ Million)
    Table 61. Pfizer Recent Development
    Table 62. Roche Holding Company Detail
    Table 63. Roche Holding Business Overview
    Table 64. Roche Holding Leukemia Therapeutic Product
    Table 65. Roche Holding Revenue in Leukemia Therapeutic Business (2018-2023) & (US$ Million)
    Table 66. Roche Holding Recent Development
    Table 67. Celgene Corporation Company Detail
    Table 68. Celgene Corporation Business Overview
    Table 69. Celgene Corporation Leukemia Therapeutic Product
    Table 70. Celgene Corporation Revenue in Leukemia Therapeutic Business (2018-2023) & (US$ Million)
    Table 71. Celgene Corporation Recent Development
    Table 72. Ariad Pharmaceuticals Company Detail
    Table 73. Ariad Pharmaceuticals Business Overview
    Table 74. Ariad Pharmaceuticals Leukemia Therapeutic Product
    Table 75. Ariad Pharmaceuticals Revenue in Leukemia Therapeutic Business (2018-2023) & (US$ Million)
    Table 76. Ariad Pharmaceuticals Recent Development
    Table 77. Clavis Pharma Company Detail
    Table 78. Clavis Pharma Business Overview
    Table 79. Clavis Pharma Leukemia Therapeutic Product
    Table 80. Clavis Pharma Revenue in Leukemia Therapeutic Business (2018-2023) & (US$ Million)
    Table 81. Clavis Pharma Recent Development
    Table 82. Sunesis Pharmaceuticals Company Detail
    Table 83. Sunesis Pharmaceuticals Business Overview
    Table 84. Sunesis Pharmaceuticals Leukemia Therapeutic Product
    Table 85. Sunesis Pharmaceuticals Revenue in Leukemia Therapeutic Business (2018-2023) & (US$ Million)
    Table 86. Sunesis Pharmaceuticals Recent Development
    Table 87. Research Programs/Design for This Report
    Table 88. Key Data Information from Secondary Sources
    Table 89. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Leukemia Therapeutic Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Leukemia Therapeutic Market Share by Type: 2022 VS 2029
    Figure 3. Induction Therapy Features
    Figure 4. Consolidation Therapy Features
    Figure 5. Maintenance Therapy Features
    Figure 6. Global Leukemia Therapeutic Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 7. Global Leukemia Therapeutic Market Share by Application: 2022 VS 2029
    Figure 8. Cancer Research Centers Case Studies
    Figure 9. Diagnostic Laboratories Case Studies
    Figure 10. Hospitals andClinics Case Studies
    Figure 11. Others Case Studies
    Figure 12. Leukemia Therapeutic Report Years Considered
    Figure 13. Global Leukemia Therapeutic Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 14. Global Leukemia Therapeutic Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 15. Global Leukemia Therapeutic Market Share by Region: 2022 VS 2029
    Figure 16. Global Leukemia Therapeutic Market Share by Players in 2022
    Figure 17. Global Top Leukemia Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukemia Therapeutic as of 2022)
    Figure 18. The Top 10 and 5 Players Market Share by Leukemia Therapeutic Revenue in 2022
    Figure 19. North America Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. North America Leukemia Therapeutic Market Share by Country (2018-2029)
    Figure 21. United States Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Canada Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Europe Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Europe Leukemia Therapeutic Market Share by Country (2018-2029)
    Figure 25. Germany Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. France Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. U.K. Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Italy Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Russia Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Nordic Countries Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Asia-Pacific Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Asia-Pacific Leukemia Therapeutic Market Share by Region (2018-2029)
    Figure 33. China Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Japan Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. South Korea Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Southeast Asia Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. India Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Australia Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Latin America Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Latin America Leukemia Therapeutic Market Share by Country (2018-2029)
    Figure 41. Mexico Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Brazil Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Middle East & Africa Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Middle East & Africa Leukemia Therapeutic Market Share by Country (2018-2029)
    Figure 45. Turkey Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Saudi Arabia Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Genzyme Revenue Growth Rate in Leukemia Therapeutic Business (2018-2023)
    Figure 48. Novartis International Revenue Growth Rate in Leukemia Therapeutic Business (2018-2023)
    Figure 49. Pfizer Revenue Growth Rate in Leukemia Therapeutic Business (2018-2023)
    Figure 50. Roche Holding Revenue Growth Rate in Leukemia Therapeutic Business (2018-2023)
    Figure 51. Celgene Corporation Revenue Growth Rate in Leukemia Therapeutic Business (2018-2023)
    Figure 52. Ariad Pharmaceuticals Revenue Growth Rate in Leukemia Therapeutic Business (2018-2023)
    Figure 53. Clavis Pharma Revenue Growth Rate in Leukemia Therapeutic Business (2018-2023)
    Figure 54. Sunesis Pharmaceuticals Revenue Growth Rate in Leukemia Therapeutic Business (2018-2023)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Genzyme
Novartis International
Pfizer
Roche Holding
Celgene Corporation
Ariad Pharmaceuticals
Clavis Pharma
Sunesis Pharmaceuticals
Frequently Asked Questions
Leukemia Therapeutic report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Leukemia Therapeutic report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Leukemia Therapeutic report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Leukocarts

This report aims to provide a comprehensive presentation of the global market for Leukocarts, wit ... Read More